Normothermic ex vivo lung perfusion using a developed solution followed by orthotopic left lung transplantation (experimental study)

The continued unavailability of adequate organs for transplantation to meet the existing demand has resulted in a major challenge in transplantology. This is especially felt in lung transplantation (LTx). LTx is the only effective method of treatment for patients with end-stage lung diseases. Normothermic ex vivo lung perfusion (EVLP) has been proposed to increase the number of donor organs suitable for transplant – EVLP has proven itself in a number of clinical trials. The ability to restore suboptimal donor lungs, previously considered unsuitable for transplantation, can improve organ functionality, and thus increase the number of lung transplants. However, widespread implementation of ex vivo perfusion is associated with high financial costs for consumables and perfusate.

Objective: to test the developed solution on an ex vivo lung perfusion model, followed by orthotopic LT under experimental conditions.

Materials and methods. The experiment included lung explantation stages, static hypothermic storage, EVLP and orthotopic left LTx. Perfusion was performed in a closed perfusion system. We used our own made human albumin-based perfusion solution as perfusate. Perfusion lasted for 2 hours, and evaluation was carried out every 30 minutes. In all cases, static hypothermic storage after perfusion lasted for 4 hours. The orthotopic single-lung transplantation procedure was performed using assisted circulation, supplemented by membrane oxygenation. Postoperative follow-up was 2 hours, after which the experimental animal was euthanized.

Results. Respiratory index before lung explantation was 310 ± 40 mmHg. The PaO2/FiO2 ratio had positive growth dynamics throughout the entire EVLP procedure. Oxygenation index was 437 ± 25 mm Hg after 120 minutes of perfusion. Throughout the entire EVLP procedure, there was a steady decrease in pulmonary vascular resistance (PVR). Initial PVR was 300 ± 100 dyn×s/cm5; throughout the EVLP, PVR tended to fall, reaching 38,5 ± 12 dyn×s/cm5 at the end of perfusion.

Conclusion. A safe and effective EVLP using our perfusate is possible. The developed orthotopic left lung transplantation protocol under circulatory support conditions, supplemented by membrane oxygenation, showed it is efficient and reliable.

1. Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes DJ et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report – 2019; Focus theme: Donor and recipient size match. Journal of Heart and Lung Transplantation. 2019; 38 (10): 1042– 1055. doi: 10.1016/j.healun.2021.07.021.

2. Ohsumi A, Kanou T, Ali A, Guan Z, Hwang DM, Thomas KW et al. A method for translational rat ex vivo lung perfusion experimentation. American Journal of Physiology­Lung Cellular and Molecular Physiology. 2020; 319 (1): 61–70. doi: 10.1152/ajplung.00256.2019.

3. Chakos A, Ferret P, Muston B, Yan TD, Tian DH. Ex vivo lung perfusion versus standard protocol lung transplantation-mid-term survival and meta-analysis. Annals of Cardiothoracic Surgery. 2020; 9 (1): 1–9.

4. Nilsson T. Ex vivo Lung Perfusion – Experimental and Clinical Studies. 2018: 88.

5. Zoeller KA. Pulsatile flow does not improve efficacy in ex vivo lung perfusion. The University of Louisville s Institutional Repository. Electronic Theses and Dissertations. 2013: 1651.

6. Gautier SV, Tsirulnikova OM, Pashkov IV, Grudinin NV, Oleshkevich DO, Bondarenko DM et al. Evaluation of the efficacy of a novel perfusion solution for normothermic ex vivo lung perfusion compared with Steen solution™ (animal experimental study). Russian Journal of Transplantology and Artificial Organs. 2021; 23 (3): 82–89. doi: 10.15825/1995-1191-2021-3-82-89.

7. Gautier SV, Tsirulnikova OM, Pashkov IV, Filatov IA, Bogdanov VK, Grudinin NV et al. Normothermic ex vivo perfusion of isolated lungs in an experiment using a Russian made perfusion system. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (2): 94–101. doi: 10.15825/1995-1191-2022-2-94-101.

8. Mohan S, Chiles MC, Patzer RE, Pastan SO, Husain SA, Carpenter DJ et al. Factors leading to the discard of deceased donor kidneys in the United States. Kidney. 2018; 94 (1): 187–198. doi: 10.1016/j.kint.2018.02.016.

9. Mattar A, Chatterjee S, Loor G. Bridging to Lung Transplantation. Critical Care Clinics. 2019; 35 (1): 11–25. doi: 10.1016/j.ccc.2018.08.006.

10. Buchko MT, Sayed H, Nader SA, Catherine JS, Sanaz H et al. A low-cost Perfusate Alternative for ex vivo lung perfusion. Transplant Proc. 2020; 52 (10): 2941–2946. doi: 10.1016/j.transproceed.2020.05.007.

11. Grudinin NV, Bogdanov VK, Sharapov MG, Bunenkov NS, Mozheiko NP, Goncharov RG et al. Use of peroxiredoxin for preconditioning of heterotopic heart transplantation in a rat. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (2): 158–164. doi: 10.15825/1995-1191-2020-2-158-164.

12. Cypel M, Keshavjee S. Ex vivo Lung Perfusion. Operative Techniques in Thoracic and Cardiovascular Surgery. 2014; 19 (4): 433–442. doi: 10.1053/j.optechstcvs.2015.03.001.

13. Kotecha S, Jamie H, Jeremy F, Eldho P, Bronwyn JL, Helen W et al. Continued Successful Evolution of Exten ded Criteria Donor Lungs for Transplantation. Annals of Thoracic Surgery. 2017; 104 (5): 1702–1709.

14. Raghu G, Carbone RG. Lung Transplantation: Evolving Knowledge and New Horizons. 2018. 370. doi: 10.1007/978-3-319-91184-7.

15. Lee HJ, Hwang Y, Hwang HY, Park IK, Kang CH, Kim YW, Kim YT. Use of Extracorporeal Membrane Oxygenation Prior to Lung Transplantation Does Not Jeopardize Short-term Survival. Transplant Proc. 2015; 47 (9): 2737–2742. doi: 10.1016/j.transproceed.2015.09.061. PMID: 26680084.

16. Loor G Warnecke G, Villavicencio MA, Smith MA, Kukreja J, Ardehali A et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. The Lancet Respiratory Medicine. 2019; 7 (11): 975–984. doi: 10.1016/S22132600(19)30200-0.

17. Tane S, Noda K, Shigemura N. Ex vivo Lung Perfusion: A Key Tool for Translational Science in the Lungs. Chest. 2017; 151 (6): 1220–1228. doi: 10.1016/j.chest.2017.02.018.

18. Ordies S, Frick AE, Claes S, Schols D, Verleden SE, Raemdonck DE et al. Prone Positioning During Ex vivo Lung Perfusion Influences regional Edema Accumulation. Journal of Surgical Research. 2019; 239 (16): 300– 308. doi: 10.1016/j.jss.2019.02.003.

19. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report – 2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart and Lung Transplantation. 2016; 35 (10): 1158–1169. doi: 10.1016/j.healun.2015.08.014.